Harvard Bioscience(HBIO) - 2022 Q4 - Earnings Call Presentation

NASDAQ: HBIO Q4'22 Earnings Presentation The non-GAAP financial information provided in this presentation should be considered in addition to, not as a substitute for, the financial information provided and presented in accordance with GAAP and may be different than other companies' non-GAAP financial information. 3 "Organizational restructuring complete and setup for success in 2023!" Q4 New Product Launches Drive Growth, Expand Financial Section 7 For FY2023, we expect: ▪ Reduce debt leverage to ~ 2X leve ...